# life: ghostly psyche revisited; ghosts, zombies, gris-gris, and so on ...

<< Most people imagine philosophers as rational thinkers who spend their time developing abstract logical theories and strongly reject superstitious beliefs. But several 20th-century philosophers actively investigated spooky topics such as clairvoyance, telepathy – even ghosts.

Many of these philosophers, including Henri Bergson and William James, were interested in what was called “psychical research”. This was the academic study of paranormal phenomena including telepathy, telekinesis and other-worldly spirits. These thinkers attended seances and were attempting to develop theories about ghosts, life after death and the powers exhibited by mediums in trances. >>

AA << recent archival research has been looking at how these topics shaped 20th-century philosophy. >>️

Matyas Moravec. Many important 20th-century philosophers investigated ghosts – here’s how they explained them. Oct 24, 2024. 

https://theconversation.com/many-important-20th-century-philosophers-investigated-ghosts-heres-how-they-explained-them-241635

Also: ethno, gris-gris, neuro, zombie, perception, psychedelic, delirium, in https://www.inkgmr.net/kwrds.html 

Keywords: ethno, gris-gris, neuro, zombie, perception, psychedelic, delirium 

FonT: even G.A. Romero's zombie filmography - which, as with other "spooky" themes, I have always marginalized - still seems relevant.

https://en.m.wikipedia.org/wiki/George_A._Romero

# brain: waiting for 'magic strings', psilocybin is a 'relatively safe' drug.

<< Psilocybin-containing mushrooms are used for recreational, spiritual, self-development and therapeutic purposes. However, physiologically relatively nontoxic, adverse reactions are occasionally reported. >>

The << study investigated the 12-month prevalence and nature of magic mushroom-related adverse reactions resulting in emergency medical treatment seeking in a global sample of (9.233) people reporting magic mushroom use. >>️

️

️ << The results confirm psilocybin mushrooms are a relatively safe drug, with serious incidents rare and short lasting. Providing harm-reduction information likely plays a key role in preventing adverse effects. More research is needed to examine the detailed circumstances and predictors of adverse reactions including rarer physiological reactions. >>️

Emma I Kopra, Jason A Ferris, et al. Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms. Journal of Psychopharmacology. 1-9. doi: 10.1177/ 02698811221084063. 

Apr 7, 2022.

https://journals.sagepub.com/doi/full/10.1177/02698811221084063

<< Psilocybin is currently being investigated in clinical trials for mental health conditions across the world, including in our department, (..) It is important to draw a distinction between the use of psilocybin in clinical or research settings and recreational magic mushroom use, with partly overlapping yet distinct safety considerations and risk profiles. >> Emma Kopra. 

Beth Ellwood. Large survey suggests psilocybin is a “relatively safe” drug, with serious reactions being rare and short-lived. May 4, 2022. 

https://www.psypost.org/2022/05/large-survey-suggests-psilocybin-is-a-relatively-safe-drug-with-serious-reactions-being-rare-and-short-lived-63075

Also

keyword 'magic string' in FonT

https://flashontrack.blogspot.com/search?q=magic+string

keyword 'psychedelic' in FonT

https://flashontrack.blogspot.com/search?q=psychedelic

Keywords: brain, drugs, magic string, magic mushrooms, psilocybin, psychedelic

# pharma: a 'magical' (engineered) Escherichia coli to produce psychedelic psilocybin

<< Psilocybin, the prodrug of the psychoactive molecule psilocin, has demonstrated promising results in clinical trials for the treatment of addiction, depression, and post-traumatic stress disorder.  >>

AA << present the development of a modular biosynthetic production platform in the model microbe, Escherichia coli. (..) This is the highest psilocybin titer achieved to date from a recombinant organism and a significant step towards demonstrating the feasibility of industrial production of biologically-derived psilocybin. >>

Alexandra M.Adams, Nicholas A.Kaplan, et al. In vivo production of psilocybin in E. coli. Metabolic Engineering. Volume 56, pages 111-9. doi: 10.1016/j.ymben.2019.09.009. Sep 21, 2019.

https://www.sciencedirect.com/science/article/pii/S109671761930309X

Tanya Lewis. E. coli Could Produce a Popular Psychedelic for Therapeutic Use. Scientists engineered the bacterium to produce psilocybin. SCIAM. 322, 1, 16. Jan 2020.

https://www.scientificamerican.com/article/e-coli-could-produce-a-popular-psychedelic-for-therapeutic-use/

Also

keyword 'magic' in FonT

https://flashontrack.blogspot.com/search?q=magic